![Christopher L. Moertel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Christopher L.
Moertel is the founder of OX2 Therapeutics, Inc. where he currently holds the position of Director & Chief Medical Officer.
Actieve functies van Christopher L. Moertel
Bedrijven | Functie | Begin |
---|---|---|
OX2 Therapeutics, Inc.
![]() OX2 Therapeutics, Inc. Hospital/Nursing ManagementHealth Services OX2 Therapeutics, Inc. provides treatment of primary brain tumors and other central nervous system tumors. The company was founded by Michael Olin, Christopher L. Moertel and Sumant Dhawan in 2016 and is headquartered in Minneapolis, MN. | Oprichter | 01-01-2016 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
OX2 Therapeutics, Inc.
![]() OX2 Therapeutics, Inc. Hospital/Nursing ManagementHealth Services OX2 Therapeutics, Inc. provides treatment of primary brain tumors and other central nervous system tumors. The company was founded by Michael Olin, Christopher L. Moertel and Sumant Dhawan in 2016 and is headquartered in Minneapolis, MN. | Health Services |